70 results
8-K
EX-10.1
HRTX
Heron Therapeutics Inc
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
exchange rules (“Exchange Rules”), validly appointed an audit committee to oversee internal accounting controls whose composition satisfies
8-K
HRTX
Heron Therapeutics Inc
20 Apr 23
Heron Therapeutics Announces Commercial Leadership Changes
9:10am
by the Company without cause. Following the departures of Mr. Poyhonen and Mr. Mathews, Craig Collard, the Company’s Chief Executive Officer, will oversee
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
20 Apr 23
Heron Therapeutics Announces Commercial Leadership Changes
9:10am
and Mr. Mathews, Craig Collard, Heron’s Chief Executive Officer, will oversee Heron’s commercial organization.
“I have had the pleasure … to his contributions as we grow our acute care franchise,” said Craig Collard. “In addition, I am excited to oversee the commercial group and focus
8-K
EX-10.1
cf664urtiwonoomf
10 Aug 22
Entry into a Material Definitive Agreement
4:46pm